Author

Jabar A Faraj

Al-Mustaqbal University College, Pharmacy Department - Cited by 739 - pharmaceutics and industrial pharmacy

Biography

Jabar A Faraj currently works at the Pharmacy Department, Al-Mustaqbal University College and product manufacturing consultant to Profounda Inc drug company in Florida, USA. The most recent publications are 'Development of a Sustained Anti-plaque and Antimicrobial Chewing Gum of a Decapeptide'. In addition, paranteral controlled injectable dosage forms of oncology medicines and other small and large molecules.
Title
Cited by
Year
A model-dependent approach to correlate accelerated with real-time release from biodegradable microspheres
SS D’Souza, JA Faraj, PP DeLucaAaps Pharmscitech 6, E553-E564, 2005200
104
2005
Development of a peptide-containing chewing gum as a sustained release antiplaque antimicrobial delivery system
JA Faraj, R Dorati, A Schoubben, D Worthen, F Selmin, Y Capan, K Leung, ...Aaps Pharmscitech 8, E177-E185, 2007200
73
2007
Hydrolysis of leucine enkephalin in the nasal cavity of the rat—a possible factor in the low bioavailability of nasally administered peptides
A Hussain, J Faraj, Y Aramaki, JE TrueloveBiochemical and biophysical research communications 133 (3), 923-928, 1985198
69
1985
Stability of antimicrobial decapeptide (KSL) and its analogues for delivery in the oral cavity
DH Na, J Faraj, Y Capan, KP Leung, PP DeLucaPharmaceutical research 24, 1544-1550, 2007200
66
2007
Chewing gum of antimicrobial decapeptide (KSL) as a sustained antiplaque agent: preformulation study
DH Na, J Faraj, Y Capan, KP Leung, PP DeLucaJournal of Controlled Release 107 (1), 122-130, 2005200
64
2005
Development of risperidone PLGA microspheres
S D’Souza, JA Faraj, S Giovagnoli, PP DeLucaJournal of Drug Delivery 2014, 2014201
48
2014
Mechanism of nasal absorption of drugs. III: nasal absorption of leucine enkephalin
JA Faraj, AA Hussain, Y Aramaki, K Iseki, M Kagoshima, LW DittertJournal of pharmaceutical sciences 79 (8), 698-702, 1990199
43
1990
Microsphere delivery of Risperidone as an alternative to combination therapy
S D’Souza, J Faraj, P DeLucaEuropean Journal of Pharmaceutics and Biopharmaceutics 85 (3), 631-639, 2013201
35
2013
In vitro–in vivo correlation from lactide-co-glycolide polymeric dosage forms
S D’Souza, JA Faraj, S Giovagnoli, PP DeLucaProgress in biomaterials 3, 1-142, 2014201
31
2014
Antimicrobial peptides for plaque control
KP Leung, JJ Abercrombie, TM Campbell, KD Gilmore, CA Bell, JA Faraj, ...Advances in Dental Research 21 (1), 57-62, 2009200
29
2009
Enhanced degradation of lactide-co-glycolide polymer with basic nucleophilic drugs
S D’Souza, JA Faraj, R Dorati, PP DeLucaAdvances in Pharmaceutics 2015, 2015201
27
2015
A short term quality control tool for biodegradable microspheres
S D’Souza, JA Faraj, R Dorati, PP DeLucaAAPS PharmSciTech 15, 530-541, 2014201
27
2014
Mechanism of nasal absorption of drugs. IV: Plasma levels of radioactivity following intranasal administration of [3H] leucine enkephalin
JA Faraj, AA Hussain, Y Aramaki, K Iseki, M Kagoshima, LW DittertJournal of pharmaceutical sciences 79 (9), 768-770, 1990199
16
1990
Development of a sustained antiplaque and antimicrobial chewing gum of a decapeptide
AM Al-Ghananeem, KP Leung, J Faraj, PP DeLucaAAPS PharmSciTech 18, 2240-2247, 2017201
12
2017
Unstirred Water Layer Effects on Biodegradable Microspheres
S D’Souza, JA Faraj, PP DeLucaAdvances in Pharmaceutics 201, 20120
5
2015
Evaluation of the Wheat Germ Oil Topical Formulations for Wound Healing Activity in Rats.
R Zakaria, J FarajPakistan journal of biological sciences: PJBS 24 (6), 706-71, 2021202
5
2021
Fulvestrant formulations
JA FarajUS Patent 9,271,990, 2016201
4
2016
In vitro characterization of six month dosage forms for a GnRH antagonist
S D’Souza, S Murty, JA Faraj, PP DeLucaAdvances in pharmaceutics 2014, 2014201
3
2014
Fulvestrant formulations
JA FarajUS Patent 9,833,459, 01701
2
2017
Fulvestrant formulations
JA FarajUS Patent 0,88,663, 20920
1
2019